Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1GUSELKUMAB
(Tremfya (TN))		1件: Guselkumab (Tremfya)1件: Guselkumab (Tremfya (TN)) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬5件: 37, 41, 51, 96, 97 💬
2Guselkumab 100 mg
(Tremfya (TN))		1件: Guselkumab (Tremfya)1件: Guselkumab (Tremfya (TN)) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 37 💬
3Guselkumab Dose 1
(Tremfya (TN))		1件: Guselkumab (Tremfya)1件: Guselkumab (Tremfya (TN)) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬3件: 51, 96, 97 💬
4Guselkumab Dose 2
(Tremfya (TN))		1件: Guselkumab (Tremfya)1件: Guselkumab (Tremfya (TN)) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬3件: 51, 96, 97 💬
5Guselkumab Dose 3
(Tremfya (TN))		1件: Guselkumab (Tremfya)1件: Guselkumab (Tremfya (TN)) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
6Guselkumab Dose 4
(Tremfya (TN))		1件: Guselkumab (Tremfya)1件: Guselkumab (Tremfya (TN)) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
7Guselkumab Dose 5
(Tremfya (TN))		1件: Guselkumab (Tremfya)1件: Guselkumab (Tremfya (TN)) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
8TREMFYA1件: Guselkumab (Tremfya)1件: Guselkumab (Tremfya (TN)) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 37, 97 💬
9TREMFYA®1件: Guselkumab (Tremfya)1件: Guselkumab (Tremfya (TN)) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 37, 97 💬